[18F]-PSS232人体PET显像的辐射剂量学研究
本研究在6名健康男性志愿者中静脉注射243±3 MBq的[18F]-PSS232后行系列全身PET/CT扫描至90分钟,估算人体辐射剂量与生物分布,评价剂量限制器官及安全性。结果显示注射安全耐受,有效剂量为3.72±0.12 mSv/人(0.0153 mSv/MBq)。
要点
- [18F]-PSS232注射安全且耐受良好。
- 胆囊壁吸收剂量最高(0.2295 mGy/MBq),其次为小肠与肝脏。
- 平均有效剂量3.72±0.12 mSv/人,剂量学表现良好。
核心结论
- [18F]-PSS232是一种新型18F标记mGlu5示踪剂,人体剂量学表现良好,且安全、耐受良好。
研究设计与样本
- 研究纳入6名健康男性志愿者(平均年龄23.5±1.7岁,范围21-26岁),静脉注射243±3 MBq [18F]-PSS232后行系列全身(头顶至大腿中部)PET/CT扫描。
- 用OLINDA/EXM软件进行剂量学估算。
主要发现
- 注射[18F]-PSS232安全且耐受良好。
- 吸收剂量最高的器官为胆囊壁(0.2295 mGy/MBq)、小肠(0.0643 mGy/MBq)和肝脏(0.0547 mGy/MBq)。
- 平均有效剂量为3.72±0.12 mSv/人(范围3.61-3.96 mSv;0.0153 mSv/MBq)。
关键数值与推荐
- 胆囊壁吸收剂量0.2295 mGy/MBq,肝脏0.0547 mGy/MBq,小肠0.0643 mGy/MBq。
- 平均有效剂量3.72±0.12 mSv/人(范围3.61-3.96 mSv),即0.0153 mSv/MBq。
临床怎么用
- 该示踪剂剂量学与安全性数据支持其在人体mGlu5受体PET显像中的进一步应用,胆囊壁为受照较高器官需关注。
局限性
- 样本量小(仅6名健康男性志愿者),扫描仅至注射后90分钟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: (E)-3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-[18F]-fluoroethoxy)propyl) oxime ([18F]-PSS232) is a new PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGlu5), and has shown promising results in rodents and humans. The aim of this study was to estimate the radiation dosimetry and biodistribution in humans, to assess dose-limiting organs, and to demonstrate safety and tolerability of [18F]-PSS232 in healthy volunteers. METHODS: PET/CT scans of six healthy male volunteers (mean age 23.5 ± 1.7; 21-26 years) were obtained after intravenous administration of 243 ± 3 MBq of [18F]-PSS232. Serial whole-body (vertex to mid-thigh) PET scans were assessed at ten time points, up to 90 min after tracer injection. Calculation of tracer kinetics and cumulated organ activities were performed using PMOD 3.7 software. Dosimetry estimates were calculated using the OLINDA/EXM software. RESULTS: Injection of [18F]-PSS232 was safe and well tolerated. Organs with highest absorbed doses were the gallbladder wall (0.2295 mGy/MBq), liver (0.0547 mGy/MBq), and the small intestine (0.0643 mGy/MBq). Mean effective dose was 3.72 ± 0.12 mSv/volunteer (range 3.61-3.96 mSv; 0.0153 mSv/MBq). CONCLUSION: [18F]-PSS232, a novel [18F]-labeled mGlu5 tracer, showed favorable dosimetry values. Additionally, the tracer was safe and well tolerated.
引用
- Sah BR, Sommerauer M, Mu L, et al. Radiation dosimetry of [18F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans. EJNMMI Res. 2019. PMID: 31240594. doi:10.1186/s13550-019-0522-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。